金石亚药公告，公司全资三级子公司浙江快克药业与参股公司杭州领业医药签订了《产品推广委托协议》，涉及药品为地奈德软膏，推广期限自协议生效起至2026年12月31日，交易金额预计不高于1500万元。领业医药为公司参股公司，公司持有其32.43%的股份。该交易旨在充分利用双方在产品和渠道上的优势，对公司未来财务状况和经营成果无不利影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.